Impact of 21‐Gene Breast Cancer Assay on Treatment Decision for Patients with T1–T3, N0–N1, Estrogen Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

BACKGROUND. The ROXANE Italian prospective study evaluated the impact of the 21‐gene Recurrence Score (RS) results on adjuvant treatment decision for patients with early breast cancer. MATERIALS AND METHODS. Nine centers participated. Physicians used the RS test whenever unsure about adjuvant treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Dieci, Maria Vittoria, Guarneri, Valentina, Zustovich, Fable, Mion, Marta, Morandi, Paolo, Bria, Emilio, Merlini, Laura, Bullian, Pierluigi, Oliani, Cristina, Gori, Stefania, Giarratano, Tommaso, Orvieto, Enrico, Griguolo, Gaia, Michieletto, Silvia, Saibene, Tania, Del Bianco, Paola, De Salvo, Gian Luca, Conte, PierFranco
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853101/
https://ncbi.nlm.nih.gov/pubmed/31152079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados